Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity

作者: P.E.M Fine , J.A.C Sterne , J.M Pönnighaus , R.J.W Rees

DOI: 10.1016/S0140-6736(94)90748-X

关键词:

摘要: There is a longstanding debate over the implications of natural and vaccine-induced delayed type hypertensivity for protective immunity to mycobacterial infections. The identification correlates should help explain inconsistent behaviour BCG vaccines in different populations assist efforts devise improved vaccines. More than 70,000 subjects Karonga District, northern Malawi were skin tested with soluble antigens tubercle leprosy bacilli, then followed up five years tuberculosis incidence. Incidence rate ratios calculated compare levels prior test sensitivity, after controlling effects age, sex previous vaccination. vaccination protected against without persistent delayed-type hypersensitivity tuberculin or bacillus. In who had not received BCG, bacillus was associated strong protection leprosy. BCG-vaccinated unvaccinated subjects, there J-shaped relation between subsequent rates tuberculosis, lowest low grade sensitivity (induration 1-10 mm). This study shows that has leprosy: low-level (probably attributable environmental mycobacteria) protection, but vaccine-associated correlate vaccine-derived diseases.

参考文章(16)
P. Draper, C. Lowe, R. J. W. Rees, C. C. Shepard, Effect of purification steps on the immunogenicity of Mycobacterium leprae. British journal of experimental pathology. ,vol. 61, pp. 376- 379 ,(1980)
Guy P. Youmans, Relation between delayed hypersensitivity and immunity in tuberculosis. The American review of respiratory disease. ,vol. 111, pp. 109- ,(2015) , 10.1164/ARRD.1975.111.2.109
M. D. GUPTE, D. S. ANANTHARAMAN, B. NAGARAJU, S. KANNAN, R. S. VALLISHA YEE, Experiences with Mycobacterium leprae soluble antigens in a leprosy endemic population. Leprosy Review. ,vol. 61, pp. 132- 144 ,(1990) , 10.5935/0305-7518.19900012
George W. Comstock, Identification of an Effective Vaccine Against Tuberculosis The American review of respiratory disease. ,vol. 138, pp. 479- 480 ,(1988) , 10.1164/AJRCCM/138.2.479
A. S. Mustafa, T. Godal, H. K. Gill, Induction of delayed-type hypersensitivity in human volunteers immunized with a candidate leprosy vaccine consisting of killed Mycobacterium leprae. Bulletin of The World Health Organization. ,vol. 64, pp. 121- 126 ,(1986)
C. Tamondong, R. Quagliato, M. Matejka, Mg Mg Gyi, V. Martínez Domínguez, T. Sundaresan, K. Uemura, L. M. Bechelli, P. Gallego Garbajosa, M. Altmann, V. Engler, BCG vaccination of children against leprosy: seven-year findings of the controlled WHO trial in Burma. Bulletin of The World Health Organization. ,vol. 48, pp. 323- 334 ,(1973)
J.M. Ponnighaus, E. Msosa, P.J.K. Gruer, N.G. Liomba, P.E.M. Fine, J.A.C. Sterne, R.J. Wilson, L. Bliss, P.A. Jenkins, S.B. Lucas, Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. The Lancet. ,vol. 339, pp. 636- 639 ,(1992) , 10.1016/0140-6736(92)90794-4
Arthur M. Dannenberg, Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Clinical Infectious Diseases. ,vol. 11, ,(1989) , 10.1093/CLINIDS/11.SUPPLEMENT_2.S369